Author: Zacks Small Cap Research

1495051525367510 / 663 POSTS
By John Vandermosten, CFANASDAQ:ONCYTSE:ONCOver the last week or so, Oncolytics (NASDAQ:ONCY) (TSE:ONC) has experienced a flurry of activity from announcing a research collaboration with the Keck School of Medicine, to raising additional cash in prep ...
By Brian Marckx, CFANASDAQ:GNMXREAD THE FULL RESEARCH REPORTQ1 2018 Results / Operational Update: Pipeline Development Timelines Tracking Prior Expectations… Aevi Genomic Medicine (NASDAQ:GNMX) reported Q1 financial results and provided a business up ...
By David Bautz, PhDNASDAQ:BVXVREAD THE FULL RESEARCH REPORTBusiness UpdatePhase 3 Study of M-001 Set to Commence in 2H18BiondVax Pharmaceuticals,Ltd. (NASDAQ:BVXV) is a biopharmaceutical company developing a universal influenza vaccine (M-001) design ...
By David Bautz, PHDNASDAQ:VKTXREAD THE FULL RESEARCH REPORTBusiness UpdateMadrigal Data Provides Positive Read-Through for VK2809On May 31, 2018, Madrigal Pharmaceuticals, Inc. (MDGL) announced positive results from the Phase 2 trial of MGL-3196, the ...
By John Vandermosten, CFATSE:PMN.TOOTC:ARFXFNASDAQ:BIIBProMIS Neurosciences Inc. (TSE:PMN.TO) (OTC:ARFXF) is a Toronto-based, neurodegenerative disease-focused biotechnology company developing a portfolio of monoclonal antibodies (mAbs) for Alzheimer ...
By Grant Zeng, CFATSX:DMA.VThe Techpool Purchase:On May 21, 2018, Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH, 2607.HK) announced that the Company entered into a Share Purchase Agreement with Takeda  Pharma AG. Pursuant to the agreement, Sh ...
By Steven Ralston, CFANASDAQ:IFMKDuring the first five months of 2018, iFresh (NASDAQ:IFMK) has implemented several initiatives that should generate organic sales growth. First, the company’s supermarket in Orland has been upgraded; second, iFresh’s ...
By Brian Marckx, CFANASDAQ:EYEGQ1 Financial Results, Operating UpdateEyeGate (NASDAQ:EYEG) reported Q1 2018 financial results and provided a business update. As it relates to the financials, Q1 included a milestone (of sorts) in that it included init ...
By David Bautz, PhDNASDAQ:SPHSBusiness UpdateSophiris Bio Inc. (NASDAQ:SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign prostatic hyperplasia (BPH). The company’s lead cand ...
By Brian Marckx, CFANASDAQ:VIVEViveve (NASDAQ:VIVE) reported Q1 2018 financial results and provided a business update. Despite what we’d characterize as a pretty disappointing start to the year, management reiterated their previously issued 2018 reve ...
1495051525367510 / 663 POSTS